ARCHIVES

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 30 No. 38 | October 8, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal

January 26, 1979

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

June 18, 1993

More Oncopathology Research Asked

June 30, 1978

Minority CCOP Applications Not Yet Reviewed

December 15, 1989

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

NIH Braces For HHS Rulings ON Travel To Major Meetings.

July 20, 2001